Vertex Pharmaceuticals Inc. buy Morgan Stanley
Start price
03.12.25
/
50%
€375.90
Target price
03.12.26
€443.40
Performance (%)
10.15%
Price
22:26
€414.05
Summary
This prediction is currently active. The prediction currently has a performance of 10.15%. This prediction currently runs until 03.12.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 0.527% | 0.527% |
| iShares Core DAX® | 1,93 % | -2,11 % |
| iShares Nasdaq 100 | -0,18 % | -5,90 % |
| iShares Nikkei 225® | 7,08 % | 6,46 % |
| iShares S&P 500 | -0,20 % | -3,67 % |
Comments by Morgan_Stanley for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $516.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€420.00
19:15
19:15
-
13.02.27
13.02.27
-1.42%
22:26
22:26
